A REVIEW OF TREATMENT FOR ALZHEIMER'S DISEASE
Burlapalle Subhashini
, Brunda M A , Bindu M A , Navya T N , Ediga Koushik
Alzheimer’s disease, Streptozocin , Disorder , Dementia , Neurons
Abstract
Progressive cognitive impairment is the hallmark of Alzheimer's disease. For those 65 years of age and older, it is the most prevalent kind of dementia. The entire brain mass decreases with Alzheimer’s - the tissue experiences progressively more limited nerve cells and networks. Pathologically Alzheimer’s disease is caused because of the intracellular neurofibrillary tangles and extracellular amyloidal protein which results in the deposition of plaques which obstruct the communication between the nerve cells resulting in neurodegenerative disease. The main two available treatments for Alzheimer’s disease are Cholinesterase inhibitors with N-methyl D-Aspartate antagonists . In adding to this lesser known treatments such as accessibility of newer atypical anti-psychotics, anti-depressants, hormonal replacement therapy, anti-oxidants, and HMG Co-A reductase inhibitors.
"A REVIEW OF TREATMENT FOR ALZHEIMER'S DISEASE", JETNR - JOURNAL OF EMERGING TRENDS AND NOVEL RESEARCH (www.JETNR.org), ISSN:2984-9276, Vol.4, Issue 6, page no.c198-c204, June-2026, Available :https://rjpn.org/JETNR/papers/JETNR2606250.pdf
Volume 4
Issue 6,
June-2026
Pages : c198-c204
Paper Reg. ID: JETNR_235310
Published Paper Id: JETNR2606250
Downloads: 00050
Research Area: Pharmacy All
Country: Chikkaballapur, Karnataka, India
ISSN: 2984-9276 | IMPACT FACTOR: 9.87 Calculated By Google Scholar | ESTD YEAR: 2023
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.87 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: RJPN (IJPublication) Janvi Wave
